----

| ☒ | QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2017 |
|---------|-----------------------------------------------------------------------------------------------------------------------------------|
| OR      |
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934                                          |
| Large Accelerated Filer                     | ☐ |   | Accelerated Filer         | ☐ |
|---------------------------------------------|---------|--------|---------------------------|---------|
| Non-accelerated Filer                       | ☐ |   | Smaller Reporting Company | ☒ |
| Emerging Growth Company                     | ☐ |   |                      |    |
| (Do not check if smaller reporting company) |    |   |                      |

----

----

Table of Contents

|          | PAGE                                                                                  |
|---------------|---------------------------------------------------------------------------------------|
|          |                                                                                  |
| PART I        | 3                                                                                     |
|          |                                                                                  |
| Item 1.       | Financial Statements.                                                                 | 3 |
|          |                                                                                  |   |
|          | Unaudited Consolidated Balance Sheets                                                 | 3 |
|          |                                                                                  |   |
|          | Unaudited Consolidated Statements Of Operations                                       | 4 |
|          |                                                                                  |   |
|          | Unaudited Consolidated Statements Of Cash Flows                                       | 5 |
|          |                                                                                  |   |
|          | Notes to Unaudited Consolidated Financial Statements                                  | 6 |
|          |                                                                                  |   |
| Item 2.       | Management's Discussion and Analysis of Financial Condition and Results ofOperations. | 11 |
|          |                                                                                  |   |
| Item 3.       | Quantitative and Qualitative Disclosures about Market Risk.                           | 16 |
|          |                                                                                  |   |
| Item 4.       | Controls and Procedures.                                                              | 16 |
|          |                                                                                  |   |
| PART II       | 16                                                                                    |
|          |                                                                                  |
| Item 1.       | Legal Proceedings.                                                                    | 16 |
|          |                                                                                  |   |
| Item 1A.      | Risk Factors.                                                                         | 16 |
|          |                                                                                  |   |
| Item 6.       | Exhibits.                                                                             | 17 |
|          |                                                                                  |   |
| Signatures    | 19                                                                                    |
|          |                                                                                  |
| Exhibit Index | 20                                                                                    |

----

Table of Contents

| ITEM 1. | FINANCIAL STATEMENTS. |
|---------|-----------------------|

|                                                                                                                                           |   | June 30, |        |    | December 31, |   |
|------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------|-------------|---------|--------------|--------|
| ASSETS                                                                                                                                         |   | 2017     |        |    | 2016         |   |
| Current Assets:                                                                                                                                |   |     |        |    |         |   |
| Prepaid expenses                                                                                                                               |   |     | 35,748      |    |         |   | 57,011 |   |
| Total Current Assets                                                                                                                           |   |     | 35,748      |    |         |   | 57,011 |   |
|                                                                                                                                           |   |     |        |    |         |   |   |   |
| TOTAL ASSETS                                                                                                                                   |   | $        | 35,748      |    |         | $      | 57,011 |   |
|                                                                                                                                           |   |     |        |    |         |   |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIENCY                                                                                                       |   |     |        |    |         |   |   |   |
| Current Liabilities:                                                                                                                           |   |     |        |    |         |   |   |   |
| Bank overdraft                                                                                                                                 |   | $        | -           |    |         | $      | 211 |   |
| Accounts payable and accrued liabilities                                                                                                       |   |     | 3,101,602   |    |         |   | 2,731,879 |   |
| Derivative liabilities                                                                                                                         |   |     | 25,087      |    |         |   | 270,581 |   |
| Convertible promissory notes, net of discount of $Nil and $8,872 respectively                                                                  |   |     | 19,723      |    |         |   | 324,586 |   |
| Convertible loans payable – third parties                                                                                                |   |     | 210,951     |    |         |   | 191,510 |   |
| Short term loans payable                                                                                                                       |   |     | 16,708      |    |         |   | 16,215 |   |
| Convertible loans payable – related parties                                                                                              |   |     | 707,871     |    |         |   | 615,163 |   |
| Liability for issuable shares                                                                                                                  |   |     | 139,053     |    |         |   | - |   |
| Deferred lease inducement                                                                                                                      |   |     | -           |    |         |   | 1,260 |   |
| Total Current Liabilities                                                                                                                      |   |     | 4,220,995   |    |         |   | 4,151,405 |   |
| TOTAL LIABILITIES                                                                                                                              |   |     | 4,220,995   |    |         |   | 4,151,405 |   |
|                                                                                                                                           |   |     |        |    |         |   |   |   |
| Commitments and Contingencies                                                                                                                  |   |     |        |    |         |   |   |   |
|                                                                                                                                           |   |     |        |    |         |   |   |   |
| Stockholders' Deficiency                                                                                                                       |   |     |        |    |         |   |   |   |
| Preferred stock, $0.00001 par value, 100,000,000 shares authorized,95,000,000 Series A preferred shares issued and outstanding                 |   |     | 950         |    |         |   | 950 |   |
| Common stock, $0.00001 par value, 15,000,000,000 shares authorized,9,905,548,954 and 8,098,742,772 shares issued and outstanding, respectively |   |     | 99,056      |    |         |   | 80,988 |   |
| Additional paid-in capital                                                                                                                     |   |     | 40,323,656  |    |         |   | 30,965,822 |   |
|   Assignment of liabilities                                                                                                               |   |     | (3,806,946  | )  |         |   | - |   |
| Accumulated deficit                                                                                                                            |   |     | (40,801,963 | )       |         |   | (35,142,154 | ) |
|                                                                                                                                           |   |     |        |    |         |   |   |   |
| Total Stockholders' Deficiency                                                                                                                 |   |     | (4,185,247  | )       |         |   | (4,094,394 | ) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY                                                                                                 |   | $        | 35,748      |    |         | $      | 57,011 |   |

----

Table of Contents

|                                           |   | Three Months Ended |          |   | Six months Ended |   |
|------------------------------------------------|--------|--------------------|---------------|--------|------------------|--------|
|                                           |   | June 30,           |          |   | June 30,         |   |
|                                           |   | 2017               |          |   | 2016             |   |   | 2017 |   |   | 2016 |   |
|                                           |   |               |          |   |             |   |   |   |   |   |   |   |
|                                           |   |               |          |   |             |   |   |   |   |   |   |   |
| Operating Expenses                             |   |               |          |   |             |   |   |   |   |   |   |   |
| General and administration                     |   | $                  | 5,423,306     |   |             | $      | 1,070,197 |   |   | $ | 5,650,079 |   |   | $ | 1,682,258 |   |
| Selling and marketing                          |   |               | 2,437         |   |             |   | 24,216 |   |   |   | 2.940 |   |   |   | 24,624 |   |
| Impairment of assets                           |   |               | -             |   |             |   | 104,018 |   |   |   | - |   |   |   | 104,018 |   |
| Depreciation                                   |   |               | -             |   |             |   | 15,767 |   |   |   | - |   |   |   | 31,533 |   |
| Operating loss                                 |   |               | (5,425,743    | )      |             |   | (1,214,198 | ) |   |   | (5,653,019 | ) |   |   | (1,842,433 | ) |
|                                           |   |               |          |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Interest and financing costs                   |   |               | (53,623       | )      |             |   | (128,805 | ) |   |   | (112,016 | ) |   |   | (194,219 | ) |
| Change in fair value on derivative liabilities |   |               | (6,347        | )      |             |   | (103,033 | ) |   |   | (3,012 | ) |   |   | (145,462 | ) |
| Gain on extinguishment of derivative liability |   |               | 227,196       |   |             |   | - |   |   |   | 227,196 |   |   |   | - |   |
| Foreign exchange loss                          |   |               | (89,507       | )      |             |   | (6,594 | ) |   |   | (118,958 | ) |   |   | (78,148 | ) |
|                                           |   |               |          |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Net Loss                                       |   | $                  | (5,348,024    | )      |             | $      | (1,452,630 | ) |   | $ | (5,659,809 | ) |   | $ | (2,260,262 | ) |
|                                           |   |               |          |   |             |   |   |   |   |   |   |   |   |   |   |   |
|                                           |   |               |          |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted net loss per share           |   | $                  | (0.00         | )      |             | $      | (0.00 | ) |   | $ | (0.00 | ) |   | $ | (0.00 | ) |
|                                           |   |               |          |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average shares used in calculating    |   |               |          |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted net loss per share           |   |               | 9,410,988,514 |   |             |   | 7,720,485,653 |   |   |   | 8,971,813,510 |   |   |   | 7,021,636,272 |   |

----

Table of Contents

|                                                                                                    |   | Six months Ended |       |
|---------------------------------------------------------------------------------------------------------|--------|------------------|------------|
|                                                                                                    |   | June 30,         |       |
|                                                                                                    |   | 2017             |       |   | 2016 |   |
|                                                                                                    |   |             |       |   |   |   |
| CASH FLOWS FROM OPERATING ACTIVITIES                                                                    |   |             |       |   |   |   |
| Net Loss                                                                                                |   | $                | (5,659,809 | ) |   | $ | (2,260,262 | ) |
| Adjustment to reconcile net loss to cash used in operating activities:                                  |   |             |       |   |   |   |   |   |
| Depreciation                                                                                            |   |             | -          |   |   |   | 31,533 |   |
| Stock based compensation                                                                                |   |             | 5,318,964  |   |   |   | 448,500 |   |
| Change in fair value on derivative liabilities                                                          |   |             | 3,012      |   |   |   | 145,462 |   |
| Gain on extinguishment of derivative liability                                                          |   |             | (227,196   | ) |   |   | - |   |
| Impairment of assets                                                                                    |   |             | -          |   |   |   | 104,018 |   |
| Interest and penalties                                                                                  |   |             | 101,164    |   |   |   | 106,687 |   |
| Deferred lease inducement                                                                               |   |             | (1,260     | ) |   |   | (6,554 | ) |
| Amortization of debt discount                                                                           |   |             | 8,872      |   |   |   | 87,024 |   |
| Unrealized foreign exchange loss                                                                        |   |             | 29,764     |   |   |   | 38,251 |   |
| Changes in operating assets and liabilities:                                                            |   |             |       |   |   |   |   |   |
| (Increase) decrease in prepaid expenses and deposit                                                     |   |             | 21,263     |   |   |   | 50,828 |   |
| Increase (decrease) in accounts payable and accrued liabilities                                         |   |             | 404,965    |   |   |   | 930,315 |   |
| NET CASH USED IN OPERATING ACTIVITIES                                                                   |   |             | (261       | ) |   |   | (324,198 | ) |
|                                                                                                    |   |             |       |   |   |   |   |   |
|                                                                                                    |   |             |       |   |   |   |   |   |
| CASH FLOWS FROM FINANCING ACTIVITIES                                                                    |   |             |       |   |   |   |   |   |
| Proceeds from short term loans payable                                                                  |   |             | 472        |   |   |   | - |   |
| Decrease in bank indebtedness                                                                           |   |             | (211       | ) |   |   | - |   |
| Proceeds from other convertible notes ($150,556 from related parties in 2016)                           |   |             | -          |   |   |   | 319,409 |   |
| NET CASH PROVIDED BY FINANCING ACTIVITIES                                                               |   |             | 261        |   |   |   | 319,409 |   |
|                                                                                                    |   |             |       |   |   |   |   |   |
| Effect of exchange rate changes on cash                                                                 |   |             | -          |   |   |   | 68 |   |
|                                                                                                    |   |             |       |   |   |   |   |   |
| NET (DECREASE) INCREASE IN CASH                                                                         |   |             | -          |   |   |   | (4,721 | ) |
| CASH - BEGINNING OF PERIOD                                                                              |   |             | -          |   |   |   | 4,998 |   |
| CASH - END OF PERIOD                                                                                    |   | $                | -          |   |   | $ | 277 |   |
| SUPPLEMENTAL CASH FLOW INFORMATION                                                                      |   |             |       |   |   |   |   |   |
| Income tax paid                                                                                         |   | $                | -          |   |   | $ | - |   |
| Interest paid                                                                                           |   | $                | -          |   |   | $ | - |   |
| SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES                                    |   |             |       |   |   |   |   |   |
| Conversion of promissory notes into common shares                                                       |   | $                | 60,954     |   |   | $ | 217,151 |   |
| Convertible loan payable for expenses paid directly by lender                                           |   | $                | 27,151     |   |   | $ | - |   |
| Stock issued to related party for current and future settment of accounts payable and convertible debts |   | $                | 4,135,037  |   |   | $ | - |   |
| Settlement of promissory notes and accounts payable by FE Pharmacy, Inc.                      |   | $                | 328,091    |   |   | $ | - |   |

----

Table of Contents

----

Table of Contents

----

Table of Contents

| Face amount                |   | Interest rate |   | Due date | Conversion price per share |
|----------------------------|--------|---------------|--------|----------|----------------------------|
|                       |   |          |   |     |        |
| Promissory note of $50,000 |   |          | 12%    |     | February 3, 2017           | 65% of the lowest trading price over the last 25 trading days |
|                                                                             |   | June 30, |     |
|----------------------------------------------------------------------------------|--------|----------|----------|
|                                                                             |   | 2017     |     |
| Fair value as at Beginning of Period                                             |   | $        | 270,581  |   |
| Elimination associated with payment of the note in cash by FE Pharmacy Inc. |   |     | (227,196 | ) |
| Elimination associated with conversion of promissory notes                       |   |     | (21,310  | ) |
| Change in fair value loss (gain)                                                 |   |     | 3,012    |   |
| Fair value as at End of Period                                                   |   | $        | 25,087   |   |
|                                     |   | June 30, |     |   | June 30, |   |
|------------------------------------------|--------|----------|----------|--------|----------|--------|
|                                     |   | 2017     |     |   | 2016     |   |
|                                     |   |     |     |   |     |   |
| Balance as at Beginning of Period        |   | $        | 324,586  |   |     | $      | 229,377 |   |
| Interest and Penalties                   |   |     | 45,909   |   |     |   | 54,674 |   |
| Converted into shares                    |   |     | (39,644  | )      |     |   | (128,928 | ) |
| Settled by FE Pharmacy Inc. in cash |   |     | (320,000 | )      |     |   | - |   |
| Amortization of debt discount            |   |     | 8,872    |   |     |   | 95,111 |   |
| Balance as at End of Period              |   | $        | 19,723   |   |     | $      | 250,234 |   |
| Convertible notes – short term     |   |     | (19,723  | )      |     |   | (250,234 | ) |
| Convertible notes – long term      |   | $        | -        |   |     | $      | - |   |

----

Table of Contents

| June 30, 2017          |   | Level 1 |   |   | Level 2 |   |   | Level 3 |   |   | Total  |   |
|------------------------|--------|---------|--------|--------|---------|--------|--------|---------|--------|--------|--------|--------|
| Liabilities:           |   |    |   |   |    |   |   |    |   |   |   |   |
| Derivative liabilities |   | $       | -      |   |    | $      | -      |    |   | $      | 25,087 |   |   | $ | 25,087 |   |
| December 31, 2016      |   | Level 1 |   |   | Level 2 |   |   | Level 3 |   |   | Total   |   |
|------------------------|--------|---------|--------|--------|---------|--------|--------|---------|--------|--------|---------|--------|
| Liabilities:           |   |    |   |   |    |   |   |    |   |   |    |   |
| Derivative liabilities |   | $       | -      |   |    | $      | -      |    |   | $      | 270,581 |   |   | $ | 270,581 |   |
|                                                                                   |   | June 30,2017 |    |   | December 31,2016 |   |
|----------------------------------------------------------------------------------------|--------|--------------|---------|--------|------------------|--------|
|                                                                                   |   |         |    |   |             |   |
| Convertible promissory notes bearing interest at 15% per annum – third party     |   | $            | 210,951 |   |             | $      | 191,510 |   |
| Convertible promissory notes bearing interest at 15% per annum – related parties |   |         | 707,871 |   |             |   | 615,163 |   |
|                                                                                   |   | $            | 918,822 |   |             | $      | 806,673 |   |
|                                                       | June 30,2017 |   | December 31,2016 |   |
|------------------------------------------------------------|--------------|--------|------------------|--------|
|                                                       |         |   |             |   |
| Non-interest bearing short term funding from third parties |         | $      | 16,708           |   |   | $ | 16,215 |   |
|                                                       |         | $      | 16,708           |   |   | $ | 16,215 |   |

----

Table of Contents

----

Table of Contents

| ITEM 2. | MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
|---------|----------------------------------------------------------------------------------------|

----

Table of Contents

|   | Project Description                  | Kallo SPV                |
|--------|--------------------------------------|--------------------------|
| 1      | Tamale Military Hospital project     | K-TMH Ghana Limited      |
| 2      | Cape Coast Teaching Hospital project | K-UCC Cape Coast Limited |
| 3      | Sunyani Teaching Hospital project    | K-UENR Sunyani Limited   |
| 4      | Ho Teaching Hospital project         | K-UHAS Ho Limited        |

----

Table of Contents

|  | ☐ | MobileCareTM – a mobile trailer that opens into a state of the art clinical setup in a vehicle equipped with the latest technology in healthcare.   More than just a facility, MobileCare TM can instantly connect the onboard physician with specialists for on-demand consultation via satellite through its Telehealth system. This is truly a holistic approach to delivering healthcare to the remotely located. For many rural communities, the nearest hospital, doctor or nurse may be hundreds of kilometers away. In many cases, this gap can be bridged using Telehealth technology that allows patients, nurses and doctors to talk as if they were in the same room. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | ☐ | RuralCareTM – prefabricated modular healthcare units focused in rural areas where no roads infrastructure is available.  They are equipped to provide primary healthcare including X-Ray, ultrasound, surgery, pharmacy and lab services.  Ranging from 1,200 to 3,800 square feet, these clinics can be up and running in disaster zones or rural areas in as little as one week.  Similar to the MobileCare TM product, RuralCare TM also utilizes satellite communications to access the Telehealth system. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | ☐ | Global response center – located in the Kallo headquarters in Canada, this is the escalation point for the coordination of delivery of Telehealth and eHealth support. It consists of both the Clinical Command Center and the Administrative Command Center. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | ☐ | Regional response centers, Clinical and Administrative Command centers – located in the urban area hospitals and connected with satellite communications, these centers coordinate all aspects of the healthcare delivery solution with the Mobile clinics and Rural clinics including clinical services, Telehealth services, pharmacy and medical consumable coordination as well as escalations to the Global response center. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | ☐ | Kallo University – provides education, training and development of local resources for all aspects of the healthcare delivery which includes clinical, engineering and administration. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | ☐ | Emergency Medical Services – provides ground and air ambulance vehicles for emergency patient transport.   |
|--|---------|----------------------------------------------------------------------------------------------------------------------------|

----

| 1. | To follow-up completion of the financing process with financiers and the respective governments. |
|----|--------------------------------------------------------------------------------------------------|

| 2. | To pursue working capital raise with Financial institutions and private placements. |
|----|-------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

| ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
|---------|-------------------------------------------------------------|

| ITEM 4. | CONTROLS AND PROCEDURES. |
|---------|--------------------------|

| ITEM 1. | LEGAL PROCEEDINGS. |
|---------|--------------------|

| ITEM 1A. | RISK FACTORS. |
|----------|---------------|

----

Table of Contents

| ITEM 6. | EXHIBITS. |
|---------|-----------|

|    |                                                                                                         | Incorporated by reference | Filed    |
|---------|--------------------------------------------------------------------------------------------------------------|---------------------------|----------|
| Exhibit | Document Description                                                                                         | Form                      | Date     | Number | herewith |
|    |                                                                                                         |                      |     |   |   |
| 2.1     | Articles of Merger                                                                                           | 8-K                       | 1/21/11  | 2.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.1     | Articles of Incorporation                                                                                    | SB-2                      | 3/05/07  | 3.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.2     | Bylaws                                                                                                       | SB-2                      | 3/05/07  | 3.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.3     | Amended Articles of Incorporation (11/23/2015)                                                               | 8-K                       | 12/02/15 | 3.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 4.1     | Specimen Stock Certificate                                                                                   | SB-2                      | 3/05/07  | 4.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.1    | Agreement with Rophe Medical Technologies Inc. dated December 11, 2009                                       | 10-K                      | 3/31/10  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.2    | Amended Agreement with Rophe Medical Technologies Inc. dated December 18, 2009                               | 10-K                      | 3/31/10  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.3    | Amended Agreement with Rophe Medical Technologies Inc. dated March 16, 2010                                  | 10-K                      | 3/31/10  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.4    | Investment Agreement with Kodiak Capital Group, LLC dated October 20, 2014                                   | S-1                       | 10/30/14 | 10.6 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.5    | Amended Agreement with Jarr Capital Corp.                                                                    | 8-K                       | 2/22/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.6    | Termination of Employment Agreement with John Cecil                                                          | 8-K                       | 2/22/11  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.7    | Termination of Employment Agreement with Vince Leitao                                                        | 8-K                       | 2/22/11  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.8    | Termination of Employment Agreement with Samuel Baker                                                        | 8-K                       | 2/22/11  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.9    | Services Agreement with Buchanan Associates Computer Consulting Ltd.                                         | 10-K                      | 5/18/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.10   | Equipment Lease Agreement with Buchanan Associates Computer Consulting Ltd.                                  | 10-K                      | 5/18/11  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.11   | Agreement with Mansfield Communications Inc.                                                                 | 10-K                      | 5/18/11  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.12   | Agreement with Watt International Inc.                                                                       | 10-K                      | 5/18/11  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.13   | Pilot EMR Agreement with Nexus Health Management Inc.                                                        | 10-K                      | 5/18/11  | 10.5 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.14   | 2011 Non-Qualified Stock Option Plan                                                                         | S-8                       | 6/27/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.15   | Multimedia Contractual Agreement with David Miller                                                           | 8-K                       | 10/28/11 | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.16   | Strategic Alliance Agreement with Petro Data Management Services Limited and Gateway Global Fabrication Ltd. | 8-K                       | 11/02/11 | 10.1 |   |

----

Table of Contents

| 10.17   | Independent Contractor Agreement with Savers Drug Mart                                                                                 | 8-K     | 1/26/12 | 10.1   |   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------|---------|---------|--------|--------|
|    |                                                                                                                                   |    |    |   |   |
| 10.18   | 2012 Non-Qualified Stock Option Plan                                                                                                   | S-8     | 9/06/12 | 10.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.19   | Memorandum of Offering with Ministry of Health of Republic of Ghana                                                                    | S-1/A-3 | 6/26/13 | 10.32  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.20   | Addendum to Investment Agreement with Kodiak                                                                                           | S-1/A-4 | 7/31/13 | 10.33  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.21   | Second Addendum to Investment Agreement with Kodiak                                                                                    | S-1     | 8/25/14 | 10.34  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.22   | Email from Kodiak                                                                                                                      | S-1/A-1 | 9/24/14 | 10.35  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.23   | Email from Kodiak                                                                                                                      | S-1/A-1 | 9/24/14 | 10.36  |   |
|    |                                                                                                                                   |    |    |   |   |
| 14.1    | Code of Ethics                                                                                                                         | S-1     | 8/25/14 | 14.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 16.1    | Letter from Collins Barrow Toronto LLP                                                                                                 | 8-K/A-1 | 2/15/12 | 16.3   |   |
|    |                                                                                                                                   |    |    |   |   |
| 16.2    | Letter from Schwartz Levitsky Feldman LLP                                                                                              | 8-K/A-3 | 8/13/14 | 16.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 21.1    | List of Subsidiary Companies                                                                                                           | 10-K    | 3/31/10 | 21.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 31.1    | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 32.1    | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002         |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 99.1    | Audit Committee Charter                                                                                                                | 10-K    | 4/15/08 | 99.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.2    | Disclosure Committee Charter                                                                                                           | 10-K    | 4/15/08 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.3    | FCPA Code                                                                                                                              | S-1     | 8/25/14 | 99.3   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.4    | Letter from Ministry of Health                                                                                                         | 8-K     | 6/08/15 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.5    | Letter from Minister of Health and Public Hygiene                                                                                      | 8-K     | 6/24/15 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 101.INS | XBRL Instance Document                                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.SCH | XBRL Taxonomy Extension – Schema                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.CAL | XBRL Taxonomy Extension – Calculations                                                                                           |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.DEF | XBRL Taxonomy Extension – Definitions                                                                                            |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.LAB | XBRL Taxonomy Extension – Labels                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.PRE | XBRL Taxonomy Extension – Presentation                                                                                           |    |    |   | X      |

----

Table of Contents

|   | KALLO INC.         |
|--------|--------------------|
|   | (The "Registrant") |
|   |               |   |
|   | BY:                | JOHN CECIL |
|   |               | John Cecil |
|   |               | President, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, and a Chairman of the Board of Directors |

----

Table of Contents

|    |                                                                                                         | Incorporated by reference | Filed    |
|---------|--------------------------------------------------------------------------------------------------------------|---------------------------|----------|
| Exhibit | Document Description                                                                                         | Form                      | Date     | Number | herewith |
|    |                                                                                                         |                      |     |   |   |
| 2.1     | Articles of Merger                                                                                           | 8-K                       | 1/21/11  | 2.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.1     | Articles of Incorporation                                                                                    | SB-2                      | 3/05/07  | 3.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.2     | Bylaws                                                                                                       | SB-2                      | 3/05/07  | 3.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.3     | Amended Articles of Incorporation (11/23/2015)                                                               | 8-K                       | 12/02/15 | 3.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 4.1     | Specimen Stock Certificate                                                                                   | SB-2                      | 3/05/07  | 4.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.1    | Agreement with Rophe Medical Technologies Inc. dated December 11, 2009                                       | 10-K                      | 3/31/10  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.2    | Amended Agreement with Rophe Medical Technologies Inc. dated December 18, 2009                               | 10-K                      | 3/31/10  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.3    | Amended Agreement with Rophe Medical Technologies Inc. dated March 16, 2010                                  | 10-K                      | 3/31/10  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.4    | Investment Agreement with Kodiak Capital Group, LLC dated October 20, 2014                                   | S-1                       | 10/30/14 | 10.6 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.5    | Amended Agreement with Jarr Capital Corp.                                                                    | 8-K                       | 2/22/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.6    | Termination of Employment Agreement with John Cecil                                                          | 8-K                       | 2/22/11  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.7    | Termination of Employment Agreement with Vince Leitao                                                        | 8-K                       | 2/22/11  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.8    | Termination of Employment Agreement with Samuel Baker                                                        | 8-K                       | 2/22/11  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.9    | Services Agreement with Buchanan Associates Computer Consulting Ltd.                                         | 10-K                      | 5/18/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.10   | Equipment Lease Agreement with Buchanan Associates Computer Consulting Ltd.                                  | 10-K                      | 5/18/11  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.11   | Agreement with Mansfield Communications Inc.                                                                 | 10-K                      | 5/18/11  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.12   | Agreement with Watt International Inc.                                                                       | 10-K                      | 5/18/11  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.13   | Pilot EMR Agreement with Nexus Health Management Inc.                                                        | 10-K                      | 5/18/11  | 10.5 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.14   | 2011 Non-Qualified Stock Option Plan                                                                         | S-8                       | 6/27/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.15   | Multimedia Contractual Agreement with David Miller                                                           | 8-K                       | 10/28/11 | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.16   | Strategic Alliance Agreement with Petro Data Management Services Limited and Gateway Global Fabrication Ltd. | 8-K                       | 11/02/11 | 10.1 |   |

----

Table of Contents

| 10.17   | Independent Contractor Agreement with Savers Drug Mart                                                                                 | 8-K     | 1/26/12 | 10.1   |   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------|---------|---------|--------|--------|
|    |                                                                                                                                   |    |    |   |   |
| 10.18   | 2012 Non-Qualified Stock Option Plan                                                                                                   | S-8     | 9/06/12 | 10.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.19   | Memorandum of Offering with Ministry of Health of Republic of Ghana                                                                    | S-1/A-3 | 6/26/13 | 10.32  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.20   | Addendum to Investment Agreement with Kodiak                                                                                           | S-1/A-4 | 7/31/13 | 10.33  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.21   | Second Addendum to Investment Agreement with Kodiak                                                                                    | S-1     | 8/25/14 | 10.34  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.22   | Email from Kodiak                                                                                                                      | S-1/A-1 | 9/24/14 | 10.35  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.23   | Email from Kodiak                                                                                                                      | S-1/A-1 | 9/24/14 | 10.36  |   |
|    |                                                                                                                                   |    |    |   |   |
| 14.1    | Code of Ethics                                                                                                                         | S-1     | 8/25/14 | 14.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 16.1    | Letter from Collins Barrow Toronto LLP                                                                                                 | 8-K/A-1 | 2/15/12 | 16.3   |   |
|    |                                                                                                                                   |    |    |   |   |
| 16.2    | Letter from Schwartz Levitsky Feldman LLP                                                                                              | 8-K/A-3 | 8/13/14 | 16.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 21.1    | List of Subsidiary Companies                                                                                                           | 10-K    | 3/31/10 | 21.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 31.1    | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 32.1    | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002         |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 99.1    | Audit Committee Charter                                                                                                                | 10-K    | 4/15/08 | 99.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.2    | Disclosure Committee Charter                                                                                                           | 10-K    | 4/15/08 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.3    | FCPA Code                                                                                                                              | S-1     | 8/25/14 | 99.3   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.4    | Letter from Ministry of Health                                                                                                         | 8-K     | 6/08/15 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.5    | Letter from Minister of Health and Public Hygiene                                                                                      | 8-K     | 6/24/15 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 101.INS | XBRL Instance Document                                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.SCH | XBRL Taxonomy Extension – Schema                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.CAL | XBRL Taxonomy Extension – Calculations                                                                                           |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.DEF | XBRL Taxonomy Extension – Definitions                                                                                            |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.LAB | XBRL Taxonomy Extension – Labels                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.PRE | XBRL Taxonomy Extension – Presentation                                                                                           |    |    |   | X      |